Absci to participate in the btig medtech, digital health, life science & diagnostic tools conference

Vancouver, wash., feb. 11, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upcoming btig medtech, digital health, life science & diagnostic tools conference.
ABSI Ratings Summary
ABSI Quant Ranking